RxDoctor Payments Data

Thomas Larkin, MD

Pain Medicine · Hagerstown, MDNPI 1043318587

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations.

$4,999in general payments, 2019–2025

Across 184 payments — averaging $27.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Boston Scientific$752
  • Nevro Corp.$653
  • Medtronic$491
  • Collegium Pharmaceutical, Inc.$335
  • AbbVie$271
  • plus $1K from 27 others
$8,166in research payments, 2019–2025

Across 4 payments — averaging $2041.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Scilex Pharmaceuticals Inc.$8K

What the payments were for

  • Food & beverage$4,999100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,999 in reported general payments places this provider in the 70th percentile of 144 pain medicine providers in Maryland.

See all pain medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$443,476
Medicare patients
657
Services billed
6,343

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aimovig AutoinjectorErenumab-Aooe11$6,464
Lidocaine13$1,588
Tizanidine Hcl14$772
Gabapentin35$729
Pregabalin11$543
Baclofen20$507
Buprenorphine Hcl13$414
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen17$371
Celecoxib12$197
Oxycodone Hcl11$134
Propranolol Hcl12$117
Tramadol Hcl23$108
Alprazolam19$33

Paid to pharmacies, not to this prescriber.

Other pain medicine in Hagerstown

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →